DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages
Author: A/Prof Amanda Oakley, Dermatologist, Hamilton, New Zealand, January 2016.
Calcineurin is a cellular enzyme that catalyses some processes in activated T-lymphocytes.
A calcineurin inhibitor stops calcineurin working, by binding to proteins in the cells called immunophilins. The results are:
Calcineurin inhibitors are used topically and systemically to treat various inflammatory skin diseases, especially:
Ciclosporin can be used topically, but must be compounded extemporaneously in New Zealand.
Side effects and risks of the specific calcineurin inhibitor are described in the individual topics.
As a class of drug, the main concern is the effect of calcineurin on kidney function. Suspected reasons for nephrotoxicity include:
The risk of nephrotoxicity is reduced by:
© 2021 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.